Bryan Ball
Corporate Officer/Principal chez AADI BIOSCIENCE, INC.
Fortune : 234 000 $ au 31/03/2024
Profil
Bryan Ball is currently the Chief Quality Officer & SVP at Aadi Bioscience, Inc. He previously held positions as the Chief Quality Officer at Immunomedics, Inc., Chief Quality Officer & Senior VP-Operations at Intercept Pharmaceuticals, Inc., Vice President-Global Quality at Ikaria, Inc., Vice President-Quality & Regulatory at Ben Venue Laboratories, Inc., and SVP-Global Quality, Environmental Health & Safety at Mallinckrodt LLC.
Mr. Ball has an undergraduate degree from Central Michigan University, an MBA from Westminster School, and a graduate degree from The University of North Carolina at Charlotte.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AADI BIOSCIENCES, INC.
0,41% | 23/04/2024 | 100 000 ( 0,41% ) | 234 000 $ | 31/03/2024 |
Postes actifs de Bryan Ball
| Sociétés | Poste | Début |
|---|---|---|
| AADI BIOSCIENCE, INC. | Corporate Officer/Principal | 01/08/2022 |
Anciens postes connus de Bryan Ball
| Sociétés | Poste | Fin |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Chief Operating Officer | 01/08/2022 |
Mallinckrodt LLC
 Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Corporate Officer/Principal | 01/01/2019 |
| IKARIA, INC. | Corporate Officer/Principal | 01/01/2015 |
Ben Venue Laboratories, Inc.
 Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Corporate Officer/Principal | - |
| IMMUNOMEDICS, INC. | Corporate Officer/Principal | - |
Formation de Bryan Ball
| Central Michigan University | Undergraduate Degree |
| Westminster School | Masters Business Admin |
| The University of North Carolina at Charlotte | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| AADI BIOSCIENCE, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
Ben Venue Laboratories, Inc.
Ben Venue Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Ben Venue Laboratories, Inc. develops and manufactures sterile liquid products. Its products include Lyophilized Dosages, Small Molecule Pharmaceuticals, Cytotoxics, and Potent Compounds. The company was founded by R. Templeton Smith in 1938 and is headquartered in Bedford, OH. | Health Technology |
Mallinckrodt LLC
Mallinckrodt LLC Pharmaceuticals: MajorHealth Technology Mallinckrodt LLC is proud to be one of the world's largest suppliers of both controlled substance pain medication and acetaminophen and to have over a century of leadership in helping to diagnose disease through imaging procedures. They are focused on innovative research and development programs, strong clinician relationships and a collaborative approach to new business opportunities. In short, they aim to lead a new generation of patient care by pursuing better, safer, more cost effective ways of diagnosing and treating disease to improve patient outcomes. | Health Technology |
